Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,961 | 113 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $317.80 | 15 | $0 (2024) |
| Novo Nordisk Inc | $250.26 | 16 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $154.55 | 9 | $0 (2024) |
| PFIZER INC. | $154.22 | 8 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $137.80 | 9 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $126.15 | 8 | $0 (2023) |
| Axsome Therapeutics, Inc. | $107.86 | 5 | $0 (2024) |
| Avanir Pharmaceuticals, Inc. | $87.48 | 5 | $0 (2022) |
| Lundbeck LLC | $86.77 | 5 | $0 (2024) |
| Lilly USA, LLC | $83.94 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $595.88 | 32 | Otsuka America Pharmaceutical, Inc. ($153.65) |
| 2023 | $720.50 | 40 | Otsuka America Pharmaceutical, Inc. ($107.77) |
| 2022 | $339.80 | 21 | Otsuka America Pharmaceutical, Inc. ($56.38) |
| 2021 | $305.20 | 20 | Avanir Pharmaceuticals, Inc. ($68.83) |
All Payment Transactions
113 individual payment records from CMS Open Payments — Page 5 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/02/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $12.69 | General |
| Category: Cardiovascular | ||||||
| 07/20/2021 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 06/16/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: DIABETES | ||||||
| 06/08/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: Diabetes | ||||||
| 06/04/2021 | Mylan Specialty L.P. | Yupelri (Drug) | Food and Beverage | In-kind items and services | $11.81 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 05/12/2021 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 04/29/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $20.68 | General |
| Category: Diabetes | ||||||
| 04/14/2021 | Biogen, Inc. | — | Food and Beverage | In-kind items and services | $12.02 | General |
| 03/31/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: DIABETES | ||||||
| 02/25/2021 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: Obesity | ||||||
| 02/10/2021 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $13.19 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 01/20/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: DIABETES | ||||||
| 01/11/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: Gastroenterology | ||||||
About Dawn Dansby
Dawn Dansby is a Family healthcare provider based in Athens, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/01/2015. The National Provider Identifier (NPI) number assigned to this provider is 1902276009.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dawn Dansby has received a total of $1,961 in payments from pharmaceutical and medical device companies, with $595.88 received in 2024. These payments were reported across 113 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($1,961).
Practice Information
- Specialty Family
- Location Athens, TX
- Active Since 10/01/2015
- Last Updated 06/02/2016
- Taxonomy Code 363LF0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1902276009
Products in Payments
- REXULTI (Drug) $389.79
- XIFAXAN (Drug) $137.80
- Kerendia (Drug) $126.15
- JARDIANCE (Drug) $116.79
- Rybelsus (Drug) $116.28
- Auvelity (Drug) $107.86
- NURTEC ODT (Drug) $93.68
- Ozempic (Drug) $86.10
- ELIQUIS (Drug) $79.94
- MOUNJARO (Drug) $67.02
- NUEDEXTA (Drug) $63.24
- TRELEGY ELLIPTA (Drug) $43.08
- Nuedexta (Drug) $39.02
- RYTARY (Drug) $33.18
- Austedo XR (Drug) $31.96
- YUPELRI (Drug) $30.99
- ADUHELM (Biological) $30.28
- Repatha (Biological) $29.94
- VRAYLAR (Drug) $24.69
- Yupelri (Drug) $22.87
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Athens
Amanda Pack, Np, NP
Family — Payments: $13,342
Katelyn Gillespie, Np, NP
Family — Payments: $10,429
Mona Olive, Fnp, FNP
Family — Payments: $9,229
Mary Mongare, Fnp-C, FNP-C
Family — Payments: $8,110
Christen Mccabe, Fnp, FNP
Family — Payments: $7,587
Mrs. Amanda Stephens, Np, NP
Family — Payments: $6,720